意想不到的效果:高剂量的类固醇在脱髓化中揭露了
Sai Niharika Tammineedi1, Ramit Singla2, Marilhia Cornejo Leon3
1Kamineni Institute of Medical Sciences, Nalgonda, Telangana 508254, India.
eNeurologicalSci
|June 24, 2024
概括
在高剂量类固醇治疗后,在多发性硬化症 (MS) 等脱髓化疾病中可能会出现持续性打. 梅托克洛普拉米德在一个年轻的男性患者中有效治疗了这些具有挑战性的打.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 吸收性打 (>48小时) 是一个临床挑战,特别是在神经光学炎 (NMO) 和多发性硬化症 (MS) 等脱髓化的疾病中.
- 了解打反射的神经通路和高剂量类固醇治疗的影响对于管理这种症状至关重要.
研究的目的:
- 为了调查在服用类固醇后脱髓化的患者中持续的打的原因.
- 探索脱髓化和皮质类固醇治疗之间的潜在相互作用,以触发抽.
主要方法:
- 一个21岁的男性病例报告,患有未诊断的脱髓化障碍和持续的打.
- 详细的病史,包括头和渐进的神经症状,导致MS诊断.
- 评估打触发因素,包括高剂量类固醇治疗,以及治疗反应.
主要成果:
- 这位患者在急性疾病爆发后接受高剂量类固醇治疗后出现了持续的打.
- 打是经常发生的,但在其他干预措施失败后,最终对甲托克洛普拉米德产生反应.
- 多发性硬化症 (MS) 的诊断证实具有显著的大脑和脊髓病变.
结论:
- 皮质类固醇治疗可能会在患有脱髓化疾病的患者中引发持续性打.
- 梅托克洛普拉米德显示出作为一种药理学方法来管理皮质类固醇诱导的打的潜力.
- 需要进一步研究脱髓化,类固醇治疗和打之间的关系.
相关概念视频
Skeletal Muscle Relaxants: Adverse Effects
354
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
354
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
115
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
115
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
305
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
305
Desensitization and Tachyphylaxis
1.7K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.7K
Pulmonary Tuberculosis I
231
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
231
Drugs Acting on Autonomic Ganglia: Stimulants
1.3K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.3K


